article thumbnail

Ortho-Phthalates Retain FDA Approval for Food Packaging Despite Petitions

XTalks

Last week, the US Food and Drug Administration (FDA) stood by its decision, denying a petition asking it to reevaluate the use of eight ortho-phthalates in food-contacting packaging materials. Related: Is Fiber Based Packaging the Next Trend in Sustainable Food Packaging?

article thumbnail

Celltrion’s Yuflyma receives US FDA approval for multiple conditions

Pharmaceutical Technology

Yuflyma represents the company’s fifth biosimilar and second anti-TNF biosimilar to receive US FDA approval. The regulatory approval was based on a comprehensive data package of preclinical, analytical and clinical trials. It will be offered to patients in prefilled syringe and autoinjector administration options.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lung Disease Diagnostic Xenoview Gets FDA Approval for Use with MRI

XTalks

Xenoview is a 129 Xe gas blend; it is packaged in a dose delivery bag and thus can be inhaled by a patient during a single breath hold MRI procedure (10 to 15 seconds long). After hyperpolarization, it is packaged into a dosage delivery bag. FDA approval represents achievement of a major milestone for Polarean’s technology.

article thumbnail

LumiThera’s Valeda Photobiomodulation System Gets FDA Authorization for Dry AMD

XTalks

Unlike its counterpart, wet AMD, which involves abnormal blood vessel growth, dry AMD lacks effective, FDA-approved treatment options, leaving patients at risk of significant vision loss. AMD is a leading cause of vision loss for people aged 65 and older.

article thumbnail

Merck’s Chronic Cough Drug Fails to Secure FDA Approval for Second Time

BioSpace

The regulator’s Complete Response Letter on Wednesday said Merck’s data package for gefapixant “did not meet substantial evidence of effectiveness.” The FDA also rejected the drug in 2022 due to a lack of efficacy evidence.

article thumbnail

FDA approves GSK’s Blenrep for advanced multiple myeloma

pharmaphorum

There were doubts about whether Blenrep could be approved in the US after a FDA review noted problems with ocular safety associated with the drug ahead of a meeting of the regulator’s expert advisers last month. The post FDA approves GSK’s Blenrep for advanced multiple myeloma appeared first on.

article thumbnail

ImmunoGen ELAHERE wins accelerated FDA approval for ovarian cancer

pharmaphorum

RxDx Assay – Roche’s immunohistochemistry (IHC) companion diagnostic for identifying ovarian patients eligible for ELAHERE – has been contemporaneously approved by the FDA. The post ImmunoGen ELAHERE wins accelerated FDA approval for ovarian cancer appeared first on. Additionally, VENTANA FOLR1 (FOLR1-2.1)